Parkinsons Disease With Dementia (PDD) Completed Phase 3 Trials for Rivastigmine (DB00989)

Also known as: Dementia Parkinson's Disease / Parkinson Disease Dementia / Parkinson Disease-Dementia / Parkinson's Disease Dementia / Parkinson Disease Dementia (PDD) / Parkinson's Disease Dementia (PDD) / Parkinson's Disease With Dementia / Parkinsons Disease With Dementia / Dementia With Parkinson's Disease / Parkinson Disease With Dementia

IndicationStatusPhase
DBCOND0122035 (Parkinsons Disease With Dementia (PDD))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00623103Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)Treatment